Understanding how tiny embryos make proteins
Single cell quantification of translation control in early mouse development
['FUNDING_OTHER'] · UNIVERSITY OF TEXAS AT AUSTIN · NIH-11137613
This research looks at how very early embryos create proteins, which is essential for healthy development.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF TEXAS AT AUSTIN (nih funded) |
| Locations | 1 site (AUSTIN, UNITED STATES) |
| Trial ID | NIH-11137613 on ClinicalTrials.gov |
What this research studies
In the earliest stages of life, before an embryo can make its own genetic instructions, it relies on existing instructions to build proteins. This process, called translation, is crucial for an embryo to develop properly, and if it's blocked, development stops. Researchers are using new technology to precisely measure how proteins are made in single early embryos. This will help us understand the exact steps and mechanisms involved in healthy early development.
Who could benefit from this research
Good fit: This foundational research is not directly recruiting patients but could eventually benefit future parents and children affected by congenital abnormalities or early developmental issues.
Not a fit: Patients seeking immediate treatment or direct clinical intervention for existing conditions would not directly benefit from this basic science research.
Why it matters
Potential benefit: This work could help us understand the fundamental causes of birth defects and developmental problems by revealing how early embryos develop normally.
How similar studies have performed: This approach uses a new technology to measure protein production in single embryos, making it a novel and previously unexplored area.
Where this research is happening
AUSTIN, UNITED STATES
- UNIVERSITY OF TEXAS AT AUSTIN — AUSTIN, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CENIK, CAN — UNIVERSITY OF TEXAS AT AUSTIN
- Study coordinator: CENIK, CAN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.